ACE2 and acute respiratory distress syndrome: These antecedents have supported the use of ACE2 based traps as a straightforward and feasible therapeutic strategy to fight COVID-19 upon SARS-CoV-2 neutralization and possible protection from lung injury and acute respiratory distress syndrome through reestablishing the balance of RAS [23, 24].